Novo Nordisk Shares Drop 9% as Alzheimer’s Drug Trial Misses Key Goal** **
Full article with subheadings** Novo Nordisk Stock Plummets on Alzheimer’s Drug Trial Failure Novo Nordisk’s shares plunged 9% in early trading Thursday after its experimental Alzheimer’s drug, NN-6019, failed to meet primary targets in a…
